PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect

Ion Cristóbal, Laura García-Ortí, Cristina Cirauqui, +3

Leukemia

Hematological MalignancySignal TransductionCommon EventMedicineAcute Myeloid Leukemia +11

Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia

Ion Cristóbal, Laura García-Ortí, Cristina Cirauqui, +4

Haematologica

Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1

Sofía Sirvent, Irene Soria, Cristina Cirauqui, +13

Journal of Allergy and Clinical Immunology

MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88

Cristina Benito‐Villalvilla, Cristina Cirauqui, Carmen M. Diez‐Rivero, +3

Mucosal Immunology

Recurrent InfectionsMicrobial PathogensAdaptive Immune SystemInnate Immune SystemImmunology +25

FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

Àlvaro Quintanal-Villalonga, Sonia Molina‐Pinelo, Cristina Cirauqui, +9

Journal of Thoracic Oncology

Human dendritic cells activated with MV130 induce Th1, Th17 and IL‐10 responses via RIPK2 and MyD88 signalling pathways

Cristina Cirauqui, Cristina Benito‐Villalvilla, Silvia Sánchez‐Ramón, +10

European Journal of Immunology

Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia

Laura García-Ortí, Ion Cristóbal, Cristina Cirauqui, +5

PLoS ONE

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery

Francisco Expósito, María Villalba, Miriam Redrado, +9

Cancer Letters

MedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorTumor Suppressor +7

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

Àlvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, +12

EBioMedicine

Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia

Ander Estella‐Hermoso de Mendoza, Remedios Castelló-Cros, Edurne Imbuluzqueta, +4

Journal of Biomedical Nanotechnology

Lipid PreparationNanomedicineEngineeringMedicineDrug Discovery +11